Hypercalcemia treatment adjunct

"Hypercalcemia treatment adjunct" refers to an adjunctive therapeutic indication used alongside primary interventions—such as intravenous fluid resuscitation and underlying disease-directed therapy—to manage hypercalcemia, an electrolyte disturbance characterized by abnormally elevated serum calcium concentrations This clinical state most commonly affects adults with underlying malignancies, primary hyperparathyroidism, or granulomatous and endocrine disorders, impairing neuromuscular, cardiovas...

"Hypercalcemia treatment adjunct" refers to an adjunctive therapeutic indication used alongside primary interventions—such as intravenous fluid resuscitation and underlying disease-directed therapy—to manage hypercalcemia, an electrolyte disturbance characterized by abnormally elevated serum calcium concentrations When specified as an adjunct, the indication denotes supportive pharmacotherapy integrated into broader therapeutic regimens to rapidly lower circulating calcium or maintain normocalce...

This clinical state most commonly affects adults with underlying malignancies, primary hyperparathyroidism, or granulomatous and endocrine disorders, impairing neuromuscular, cardiovascular, renal, and gastrointestinal systems Pathophysiologically, it arises from excessive osteoclastic bone resorption, increased intestinal calcium absorption, or impaired renal calcium excretion, precipitating complications such as nephrogenic diabetes insipidus, volume depletion, cardiac arrhythmias, and encepha...

Pathophysiologically, it arises from excessive osteoclastic bone resorption, increased intestinal calcium absorption, or impaired renal calcium excretion, precipitating complications such as nephrogenic diabetes insipidus, volume depletion, cardiac arrhythmias, and encephalopathy

When specified as an adjunct, the indication denotes supportive pharmacotherapy integrated into broader therapeutic regimens to rapidly lower circulating calcium or maintain normocalcemia